Skip to main content
Top
Published in: Endocrine 1/2016

01-01-2016 | Endocrine Methods and Techniques

Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation

Authors: Ihsan Ates, Mustafa Kaplan, Mahmut Yuksel, Duygu Mese, Murat Alisik, Özcan Erel, Nisbet Yilmaz, Serdar Guler

Published in: Endocrine | Issue 1/2016

Login to get access

Abstract

In this study, we aimed to examine dynamic thiol/disulfide homeostasis in type 1 diabetes mellitus (T1DM) and identify the factors associated with thiol oxidation. Thirty-eight subjects (18 male, 20 female) diagnosed with T1DM and 38 (17 male, 21 female) healthy volunteers without any known diseases were included in the study. Thiol/disulfide homeostasis concentrations were measured by a newly developed method (Erel & Neselioglu) in this study. After native thiol, total thiol and disulfide levels were determined; measures such as disulfide/native thiol, disulfide/total thiol, and native thiol/total thiol were calculated. In T1DM patients, compared to the control group, disulfide (p = 0.024), disulfide/native thiol (p < 0.001), and disulfide/total thiol (p < 0.001) were determined higher, while native thiol (p = 0.004) and total thiol (p < 0.001) levels were much lower. In the patient group, a positive correlation was determined between c-reactive protein (r = 325, p = 0.007; r = 316, p = 0.010, respectively), fasting blood glucose (r = 279, p = 0.018; r = 251, p = 0.035, respectively), and glycosylated hemoglobin (r = 341, p = 0.004; r = 332, p = 0.005, respectively) and rates of disulfide/native thiol and disulfide/total thiol. We determined that thiol oxidation increase in T1DM patients compared to the control group. We thought that hyperglycemia and chronic inflammation might be the major cause of increase in oxide thiol form. In order to determine the relationship between the status of autoimmunity and dynamic thiol/disulfide in T1DM, dynamic thiol/disulfide homeostasis in newly diagnosed-antibody positive-T1DM patients is required to be investigated.
Literature
3.
go back to reference F.Q. Schafer, G.R. Buettner, Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30(11), 1191–1212 (2001)PubMedCrossRef F.Q. Schafer, G.R. Buettner, Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30(11), 1191–1212 (2001)PubMedCrossRef
6.
go back to reference W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499–502 (1972)PubMed W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499–502 (1972)PubMed
7.
go back to reference S.D. Rodrigues, G.B. Batista, M. Ingberman, R. Pecoits-Filho, L.S. Nakao, Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. Blood Purif. 34(3–4), 231–237 (2012). doi:10.1159/000342627 PubMedCrossRef S.D. Rodrigues, G.B. Batista, M. Ingberman, R. Pecoits-Filho, L.S. Nakao, Plasma cysteine/cystine reduction potential correlates with plasma creatinine levels in chronic kidney disease. Blood Purif. 34(3–4), 231–237 (2012). doi:10.​1159/​000342627 PubMedCrossRef
16.
go back to reference D. Darmaun, S.D. Smith, S. Sweeten, B.K. Sager, S. Welch, N. Mauras, Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 54(1), 190–196 (2005)PubMedCrossRef D. Darmaun, S.D. Smith, S. Sweeten, B.K. Sager, S. Welch, N. Mauras, Evidence for accelerated rates of glutathione utilization and glutathione depletion in adolescents with poorly controlled type 1 diabetes. Diabetes 54(1), 190–196 (2005)PubMedCrossRef
17.
go back to reference P.M. Abuja, R. Albertini, Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta 306(1–2), 1–17 (2001)PubMedCrossRef P.M. Abuja, R. Albertini, Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta 306(1–2), 1–17 (2001)PubMedCrossRef
18.
go back to reference N.D. Vaziri, Causal link between oxidative stress, inflammation, and hypertension. Iran. J. Kidney Dis. 2(1), 1–10 (2008)PubMed N.D. Vaziri, Causal link between oxidative stress, inflammation, and hypertension. Iran. J. Kidney Dis. 2(1), 1–10 (2008)PubMed
19.
Metadata
Title
Determination of thiol/disulphide homeostasis in type 1 diabetes mellitus and the factors associated with thiol oxidation
Authors
Ihsan Ates
Mustafa Kaplan
Mahmut Yuksel
Duygu Mese
Murat Alisik
Özcan Erel
Nisbet Yilmaz
Serdar Guler
Publication date
01-01-2016
Publisher
Springer US
Published in
Endocrine / Issue 1/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0784-6

Other articles of this Issue 1/2016

Endocrine 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.